Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CXCL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFPI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTGER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FRAS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPHA10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADH6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC497256 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929529 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRPC5OS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00865 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM4SF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM150B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LONRF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on